Leidos nabs $12.4M contract to support vaccine efficacy

Leidos has won a single-award $12.4 million contract to improve the efficacy of vaccine candidates for prevention of anthrax and West Nile virus.

Under the contract, awarded by the National Institute of Allergy and Infectious Diseases, Leidos will prepare and assess formulations of their lead immune boosting agent compound, the company said in a release.

In order to complete the work under the contract, Leidos assembled a team that includes the Infectious Disease Research Institute, the Hawaii Biotech Institute, Pfenex Inc., Duke University, Molecular Diagnostics Services, the IIT Research Institute Inc., and Colorado State University.

About the Author

Mark Hoover is a senior staff writer with Washington Technology. You can contact him at, or connect with him on Twitter at @mhooverWT.

Reader Comments

Please post your comments here. Comments are moderated, so they may not appear immediately after submitting. We will not post comments that we consider abusive or off-topic.

Please type the letters/numbers you see above

What is your e-mail address?

My e-mail address is:

Do you have a password?

Forgot your password? Click here


  • Dive into our Contract Award database

    In an exclusive for WT Insider members, we are collecting all of the contract awards we cover into a database that you can sort by contractor, agency, value and other parameters. You can also download it into a spreadsheet. Our databases track awards back to 2013. Read More

  • Navigating the trends and issues of 2016 Nick Wakeman

    In our latest WT Insider Report, we pull together our best advice, insights and reporting on the trends and issues that will shape the market in 2016 and beyond. Read More

contracts DB

Washington Technology Daily

Sign up for our newsletter.

Terms and Privacy Policy consent

I agree to this site's Privacy Policy.